MRI-Guided Exosome Delivery via Localized Dielectric Heating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering therapeutic agents to specific tissues face challenges, particularly with surgical administration risks and the limitations of indirect methods like MRI-guided hyperthermia, which can cause unintended temperature increases and tissue damage.
Innovation Solution
A method utilizing a high-strength magnetic resonance imaging (MRI) device to apply a magnetic field of at least 3 Tesla to a target tissue, increasing local temperature and facilitating the selective delivery of therapeutic agents, such as exosomes, while minimizing core temperature elevation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If surgical administration is used to deliver therapeutic agents to target tissue, then delivery precision is improved, but patient safety deteriorates due to increased risk of infection or harm
Solution Approach 1:
The patent replaces surgical (mechanical) administration with MRI-guided focused ultrasound and thermosensitive liposome delivery. The mechanical surgical intervention is substituted with a non-invasive imaging-guided system that uses magnetic fields and thermal effects to achieve precise drug delivery without direct surgical contact, thereby maintaining delivery precision while eliminating surgical risks.
Solution Approach 2:
The patent introduces thermosensitive liposomes as an intermediary carrier system. These liposomes serve as mediators that transport therapeutic agents to the target tissue and release them in response to localized heating from focused ultrasound, guided by MRI imaging. This intermediary system enables precise delivery without requiring direct surgical intervention.
2Measurement precision
If MRI-guided focused ultrasound is used to heat target tissue for drug delivery, then delivery precision is improved, but tissue safety deteriorates due to potential overheating and damage
Solution Approach 1:
The patent implements real-time feedback control by using MRI imaging to monitor temperature changes in the target tissue during focused ultrasound heating. The MRI system provides continuous feedback on the thermal state, allowing the system to adjust the ultrasound power dynamically to maintain the temperature within the safe range (40-45°C) needed for liposome activation without causing tissue damage.
Solution Approach 2:
The patent carefully controls and changes the thermal parameter (temperature) within a specific range (40-45°C) to activate thermosensitive liposomes. By maintaining the temperature within this narrow window, the system achieves drug release while avoiding the harmful effects of excessive heating. The MRI-guided system allows precise modulation of the temperature parameter throughout the treatment process.
3Productivity
If long duration or ultra/high field strength MRI is used to improve delivery, then delivery effectiveness is improved, but patient safety deteriorates due to increased core temperature and unintended heating
Solution Approach 1:
The patent segments the heating process by using focused ultrasound to deliver energy only to the specific target tissue region, rather than using whole-body MRI heating. This spatial segmentation allows the system to achieve the necessary thermal effect for drug delivery (40-45°C) in the target area while leaving the rest of the body, including core temperature, unaffected. The MRI guidance is used only for imaging and localized temperature monitoring, not for global heating.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables safe and selective delivery of therapeutic agents to target tissues with controlled temperature increases, enhancing the efficacy of drug delivery while avoiding systemic temperature rises and potential tissue damage.
Implementation Method 1
A method utilizing a high-strength magnetic resonance imaging (MRI) device to apply a magnetic field of at least 3 Tesla to a target tissue, increasing local temperature
Data Source
AI summary
Systems, methods, and devices for administering, improving administration, or enabling the selective delivery of an agent to a target portion of a tissue are disclosed. An MRI device, at least high strength (e.g., at least 3 T), more preferably ultra high strength (e.g., at least 10 T) is directed at and applied to a target portion of a tissue, preferably brain tissue. A magnetic field is applied to the target portion of the tissue, selectively increasing local temperature and not impacting core temperature. The agent, preferably exosome carrying a therapeutic, is administered to the patient, and the agent is selectively delivered to the target portion of the tissue. Magnetic fields are optionally applied to the target portion before, during, or after administering the agent, or combinations thereof.